ATXS logo

Astria Therapeutics (ATXS) Shareholders Equity

Annual Shareholders Equity

$243.12 M
+$21.90 M+9.90%

December 31, 2023


Summary


Performance

ATXS Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXSbalance sheetmetrics:

Quarterly Shareholders Equity

$341.65 M
-$5.42 M-1.56%

September 30, 2024


Summary


Performance

ATXS Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXSbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ATXS Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.9%+85.2%
3 y3 years+497.8%+85.2%
5 y5 years+595.8%+85.2%

ATXS Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+98.8%-7.1%+243.7%
5 y5-yearat high+580.6%-7.1%+437.8%
alltimeall timeat high+432.8%-7.1%+437.8%

Astria Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$341.65 M(-1.6%)
Jun 2024
-
$347.08 M(-5.6%)
Mar 2024
-
$367.74 M(+51.3%)
Dec 2023
$243.12 M(+9.9%)
$243.12 M(+31.8%)
Sep 2023
-
$184.48 M(-7.9%)
Jun 2023
-
$200.40 M(-5.2%)
Mar 2023
-
$211.36 M(-4.5%)
Dec 2022
$221.22 M(+80.9%)
$221.22 M(+96.0%)
Sep 2022
-
$112.87 M(+13.5%)
Jun 2022
-
$99.42 M(-9.4%)
Mar 2022
-
$109.69 M(-10.3%)
Dec 2021
$122.31 M(+200.7%)
$122.31 M(-6.2%)
Sep 2021
-
$130.43 M(-4.7%)
Jun 2021
-
$136.90 M(-235.3%)
Mar 2021
-
-$101.14 M(-348.7%)
Dec 2020
$40.67 M(+13.9%)
$40.67 M(-17.5%)
Sep 2020
-
$49.31 M(-3.0%)
Jun 2020
-
$50.86 M(-5.3%)
Mar 2020
-
$53.71 M(+50.4%)
Dec 2019
$35.72 M
$35.72 M(-6.7%)
DateAnnualQuarterly
Sep 2019
-
$38.27 M(-11.7%)
Jun 2019
-
$43.36 M(-13.1%)
Mar 2019
-
$49.87 M(+42.7%)
Dec 2018
$34.94 M(+196.3%)
$34.94 M(-13.8%)
Sep 2018
-
$40.52 M(-11.6%)
Jun 2018
-
$45.81 M(+254.3%)
Mar 2018
-
$12.93 M(+9.7%)
Dec 2017
$11.79 M(-59.5%)
$11.79 M(-24.7%)
Sep 2017
-
$15.66 M(-27.3%)
Jun 2017
-
$21.55 M(-10.0%)
Mar 2017
-
$23.95 M(-17.6%)
Dec 2016
$29.09 M(-42.4%)
$29.09 M(-21.1%)
Sep 2016
-
$36.86 M(+12.3%)
Jun 2016
-
$32.81 M(-21.4%)
Mar 2016
-
$41.72 M(-17.4%)
Dec 2015
$50.49 M(-169.1%)
$50.49 M(-15.2%)
Sep 2015
-
$59.54 M(-11.9%)
Jun 2015
-
$67.59 M(+401.1%)
Mar 2015
-
$13.49 M(-118.5%)
Dec 2014
-$73.05 M(+40.0%)
-$73.05 M
Dec 2013
-$52.18 M
-

FAQ

  • What is Astria Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Astria Therapeutics?
  • What is Astria Therapeutics annual shareholders equity year-on-year change?
  • What is Astria Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Astria Therapeutics?
  • What is Astria Therapeutics quarterly shareholders equity year-on-year change?

What is Astria Therapeutics annual stockholders equity?

The current annual shareholders equity of ATXS is $243.12 M

What is the all time high annual shareholders equity for Astria Therapeutics?

Astria Therapeutics all-time high annual stockholders equity is $243.12 M

What is Astria Therapeutics annual shareholders equity year-on-year change?

Over the past year, ATXS annual stockholders equity has changed by +$21.90 M (+9.90%)

What is Astria Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of ATXS is $341.65 M

What is the all time high quarterly shareholders equity for Astria Therapeutics?

Astria Therapeutics all-time high quarterly stockholders equity is $367.74 M

What is Astria Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, ATXS quarterly stockholders equity has changed by +$157.18 M (+85.20%)